The solution eases the problem of analyte/metal surface interactions when analyzing organic acids, organophosphates, oligonucleotides, phosphopeptides, acidic glycans, and phospholipids by reverse-phase and hydrophilic interaction chromatography.
The Waters Acquity Premier Solution from Waters Corporation is a liquid chromatograph featuring Waters’ MaxPeak High Performance Surface technology, which works to improve analytical data quality and eliminate the need for passivation.
Used in combination with Acquity Premier Columns, the solution is formulated to ease the problem of analyte/metal surface interactions when analyzing organic acids, organophosphates, oligonucleotides, phosphopeptides, acidic glycans, and phospholipids by reversed phase and hydrophilic interaction chromatography. Additionally, the solution:
“The Acquity Premier Solution represents our biggest innovation in separation science since UPLC,” said Ian King, senior vice-president, Global Products, Waters Corporation, in a Feb. 10, 2021 press release. “Chromatography has an immeasurable impact on the development of novel therapeutics and treatments for innumerable diseases. The result of decades of separations science know-how along with the combined efforts of our materials scientists, chemists, and engineers, Acquity Premier addresses a long-standing problem that has held back scientific progress long enough. We firmly believe it will redefine the value that separations science brings to scientific achievement.”
Source: Waters Corporation
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
Navigating Annex 1 for Early Phase Sterile Fill Finish in Clinical Supplies
November 21st 2024Stay compliant with Annex 1 for early phase sterile fill finish processes. Discover how to implement robust contamination control strategies, integrate isolator technology, and conduct integrity testing to meet stringent European Union standards. The guide provides a comprehensive look at key elements such as PUPSIT, critical zone controls, and monitoring and training for aseptic processes.
Your Ultimate Guide for CMC Testing Support for Gene and Cell Therapy
November 21st 2024Explore the complexities of gene and cell therapy development with our comprehensive guide to Chemistry, Manufacturing, and Controls (CMC) testing. Learn how our expertise ensures the safety, potency, and quality of advanced therapies, supporting your journey from product development through regulatory approval.